EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

EASL Congress 2024

 

5-8 June, Milan
Close
N. Poster
Poster title
Applicant name
Status
  SAT-030 A visual classification scale of biliary anastomotic strictures with per-oral cholangioscopy predicts outcomes in liver transplant recipients Andres Cardenas Received Received
  SAT-036 Impact of distance from liver transplant centre on outcomes following liver transplantation - an australian single centre study Simone Chin Received Received
  FRI-039 Terlipressin therapy is associated with increased risk of colonization with multidrug-resistant bacteria in patients with decompensated cirrhosis MARCUS MÜCKE Received Received
  FRI-059 Proton pump inhibitors are not associated with an increased risk of hepatic encephalopathy Simon Johannes Gairing Received Received
  TOP-065 Outcomes of thromboelastography guided versus routine empirical or on-demand platelet transfusion in patients with liver cirrhosis and severe thrombocytopenia undergoing high-risk invasive percutaneous and vascular procedures: an open-label, randomized controlled trial Sagnik Biswas Received Received
  SAT-068 Accuracy of spleen stiffness measurement for the diagnosis of high-risk esophageal varices in patients with advanced chronic liver disease: a systematic review and individual patient data meta-analysis Elton Dajti Received Received
  TOP-072 Red blood cell distribution width-to-platelet ratio estimates the 3-year risk of decompensation in patients with metabolic dysfunction-associated steatotic liver disease-related cirrhosis Mario Romeo Received Received
  THU-101 Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis Ciro Celsa Received Received
  SAT-105 Neutrophil extracellular traps are not linked to the development of decompensation, ACLF, or death in clinically stable patients with advanced chronic liver disease Lorenz Balcar Received Received
  SAT-106 Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) predicts acute-on-chronic liver failure in patients with acute decompensation Lorenz Balcar Received Received
  WED-131 Von Willebrand factor antigen reflects portal hypertension severity in porto-sinusoidal vascular disorder and predicts liver-related outcomes Lorenz Balcar Received Received
  FRI-131 Effect of adipose-related parameters on survival in patients with cirrhosis: a systematic review and meta-analysis Xinxing Tantai Received Received
  FRI-132 Spontaneous bacterial empyema is a rare yet life-threatening complication in patients with hepatic hydrothorax Grace Wong Received Received
  TOP-143 Porto-sinusoidal vascular disease among patients undergoing surgery for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes Elton Dajti Received Received
  WED-171 Spleen stiffness and VWF-based non-invasive tests reflect severity of prehepatic and presinusoidal portal hypertension Lorenz Balcar Received Received
  WED-190 Elevated hepatic copper content in porto-sinusoidal-vascular disorder: leading down a wrong track Lorenz Balcar Received Received
  FRI-194 Risk of all-cause mortality and adverse outcomes from steatotic liver disease and its subgroups in the general population Maurice Michel Received Received
  TOP-228 CD36-mediated hepatocyte-macrophage coordination drives hepatic fibrosis in NAFLD Zhe Dai Received Received
  SAT-260 Metadoxine improves alcohol abstinence and is related to a lower risk of decompensation in cirrhosis at a median five-year follow-up: propensity score matching analysis Fatima Higuera Received Received
  TOP-277 Liver fibrosis assessed via non-invasive tests is associated with incident heart failure in a general population cohort: a UK Biobank study Theresa Hydes Received Received
  FRI-298 Insulin resistance and sarcopenia as comorbid conditions in patients with MASLD Kateryna Pivtorak Received Received
  FRI-324 Advancing in drug-induced liver injury models development: high content screening in cell-based models derived from skin tissues Antonio Segovia-Zafra Received Received
  FRI-348 Endogenous Annexin A1 has a protective effect on the liver in a diabetic mouse model Diego Dias dos Santos Received Received
  TOP-350 Differential DNA methylation as a potential drug-induced liver injury biomarker and genome-wide DNA methylation functional analysis Marina Villanueva Received Received
  TOP-351 A dual therapeutic strategy for acute liver failure: SIRP&945;-expressing extracellular vesicles from engineered mesenchymal stem cells for resolving CD47 in necroptotic hepatocytes and delivering regenerative cargo Seohyun Kim Received Received
  FRI-361 Burden of liver disease progression in patients with chronic HDV infection: a population-based study for France Lucia Parlati Received Received
  FRI-363 Association between metabolic comorbidities, severity of liver fibrosis and fibrosis regression in patients with chronic hepatitis B an individual patient data meta-analysis Lisa van Velsen Received Received
  FRI-367 Prediction of hepatocellular carcinoma risk and liver-related events in chronic hepatitis D, an international retrospective cohort study (RIDE) Lesley Patmore Received Received
  FRI-373 Impact of pregnancy on global and HBV-specific B-cell immunity Anna Pocurull Received Received
  SAT-379 Immune checkpoint proteins are associated with persistently elevated liver stiffness after successful HCV therapy in people with HIV Rubén Martín Escolano Received Received
  TOP-401 Improvement of liver stiffness during nucleo(s)tide analogue treatment in patients with chronic hepatitis B and advanced fibrosis is not associated with a reduction in hepatocellular carcinoma risk Lesley Patmore Received Received
  WED-402 Risk of hepatocellular carcinoma after curative treatment when switching from Tenofovir Disoproxil Fumarate or Entecavir to Tenofovir Alafenamide: a real-world multicenter cohort study Hyunjae Shin Received Received
  SAT-407 Long-term sustained decline of anti-HCV neutralizing antibodies in HIV/HCV-coinfected patients after therapy-induced HCV clearance Daniel Sepúlveda-Crespo Received Received
  THU-407 A new pattern for hepatitis C management in hospital: establishment and effectiveness verification Siheng Zhu Received Received
  WED-420 Evaluation of molnupiravir as an antiviral against hepatitis E virus infection Siddharth Sridhar Received Received
  WED-438 Real-world based cost effectiveness analysis of entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy CHUN-TING HO Received Received
  WED-442 Decreasing trend of hepatitis C in homeless people between 2019-2023: a retrospective study in Madrid, Spain Daniel Sepúlveda-Crespo Received Received
  THU-458 No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC Francisca Copil Received Received
  FRI-459 Outcome of targeting ATR in high replication stress murine HCC JING FANG Received Received
  THU-459 Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma: a multicentric retrospective study Clémentine ALITTI Received Received
  FRI-462 Aminoacyl-tRNA synthetases characterization and clinical potential in aggressive hepatocellular carcinoma Natalia Hermán-Sánchez Received Received
  FRI-464 Caspases compromise SLU7 and UPF1 stability and nonsense-mediated RNA decay activity during hepatocarcinogenesis Carmen Berasain Received Received
  SAT-484 Conventional and machine-learning based risk score on survival for patients with hepatocellular carcinoma CHUN-TING HO Received Received
  TOP-489 Predicting post-hepatectomy liver failure in patient with hepatocellular carcinoma: nomograms based on deep learning-analyzed gadoxetic acid-enhanced hepatobiliary phase images Boryeong Jeong Received Received
  SAT-497 A risk prediction model for hepatocellular carcinoma in general population without traditional risk factors for liver disease Byeong Geun Song Received Received
  TOP-507 Single-cell RNA sequencing-derived gene signatures reveal distinct response mechanisms to atezolizumab bevacizumab in advanced hepatocellular carcinoma Sarah Cappuyns Received Received
  TOP-511 Trends and evolution of hepatocellular carcinoma due to etiological shift from 2005 to 2020 in Germany: nationwide population-based study Josune Cabello Calleja Received Received
  SAT-515 Cholangiocarcinoma across England: evidence of regional, socioeconomic, and temporal variations in incidence, survival, routes to diagnosis and treatment Shahid Khan Received Received
  SAT-532 Distinct soluble and cellular immunological signatures in various entities of hepatitis flares Roni Souleiman Received Received
  SAT-534 Macrophage-derived IL-15 imprints peritoneal tissue-resident memory T cells during spontaneous bacterial peritonitis in patients with cirrhosis Oluwatomi Ibidapo-obe Received Received
  TOP-561 Butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis Rui Wang Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:37
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

EASL Congress 2024

 

5-8 June, Milan
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 05/06/2024 TO 05/06/2025
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.EASL2024.2024 




PosterSessionOnline
Logo Draft
 
Logo Cert